• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-6.0-120-PTX
Device Problem Occlusion Within Device (1423)
Patient Problem Reocclusion (1985)
Event Date 07/01/2014
Event Type  Injury  
Manufacturer Narrative
Pma/510(k)#: p100022/s001.Fda mdr report required based on the surgical interventions [bypass and poba] carried out and the subsequent permanent impairment of the patient [amputation of left lower limb ] following the restenosis of the limb where a zilver ptx stent was indwelling.The ziv6-35-125-6.0-120-ptx stent of lot number c791324 was implanted in the patient therefore is not available for evaluation.With the information provided a document based investigation was carried out.It was confirmed that images would not be available to support the complaint investigation and no other information could be provided.It can be noted stenosis of the lower limb followed by occlusion of the by-pass, may suggest progressing artery disease.This can be associated with the restenosis process.However, a definitive cause of this event cannot be determined.There is no evidence to suggest that this event did not occur; therefore the complaint is confirmed based on customer testimony.It can be noted that bypass, amputation of foot and restenosis of the stented artery are a known potential adverse event associated with placement of this device.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records revealed no discrepancies that could have contributed to this complaint.No information regarding patient outcome was provided.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
 
Event Description
(b)(6) 2012 the zilver ptx stent was placed in left sfa of the patient.(b)(6) 2013 by-pass procedure was performed as the left lower limb stenosed 100%.(b)(6) 2014 as by-pass made on (b)(6) 2013 got occluded, poba was performed.(b)(6) 2014 amputation of the lower limb was performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer Contact
sinead quaid
o'halloran road
national technology park
limerick 
061334440
MDR Report Key5235411
MDR Text Key31579429
Report Number3001845648-2015-00244
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
PMA/PMN Number
P100022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 10/27/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZIV6-35-125-6.0-120-PTX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date07/01/2014
Event Location Hospital
Initial Date Manufacturer Received 10/28/2015
Initial Date FDA Received11/19/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age78 YR
-
-